Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease

Medicine & Life Sciences

• Mucocutaneous Lymph Node Syndrome 100%
• Attenuated Vaccines 97%
• Passive Immunization 95%
• Intravenous Immunoglobulins 87%
• Vaccination 56%
• Mumps 45%
• Rubella 42%
• Chickenpox 42%
• Measles 39%
• Seroconversion 39%
• Measles Vaccine 12%
• Viruses 11%
• Therapeutics 10%
• Antibodies 9%
• Japan 7%
• Immunoglobulin G 6%
• Clinical Trials 5%
• Prospective Studies 5%
• Mothers 5%

Agriculture & Biology

• live vaccines 96%
• immunoglobulins 76%
• therapeutics 61%
• measles 35%
• secondary immunization 28%
• seroconversion 24%
• vaccination 17%
• medical history 7%
• antibodies 6%
• viruses 6%
• prospective studies 6%
• clinical trials 5%
• standard deviation 4%
• vaccines 4%
• Japan 3%
• dosage 2%
• methodology 1%

Social Sciences

• vaccination 43%
• Japan 3%
• present 2%